First Time Loading...
C

Changzhou Qianhong Biopharma Co Ltd
SZSE:002550

Watchlist Manager
Changzhou Qianhong Biopharma Co Ltd
SZSE:002550
Watchlist
Price: 5.34 CNY 3.09% Market Closed
Updated: May 3, 2024
Section:
 

Relative Value

The Relative Value of one Changzhou Qianhong Biopharma Co Ltd stock under the Base Case scenario is 6.94 CNY. Compared to the current market price of 5.34 CNY, Changzhou Qianhong Biopharma Co Ltd is Undervalued by 23%.

Relative Value is the estimated value of a stock based on various valuation multiples like P/E and EV/EBIT ratios. It offers a quick snapshot of a stock's valuation in relation to its peers and historical norms.

Relative Value
Base Case
6.94 CNY
Undervaluation 23%
Relative Value
Price
C
Worst Case
Base Case
Best Case

Valuation Multiples

3.2
P/S
P/S
Price to Sales
3.2
vs History
52
vs Industry
37
Median 3Y
3.2
Median 5Y
3.2
Industry
2.4
Forward
3.2
More Details
26.9
P/E
P/E
Price to Earnings
26.9
vs History
31
vs Industry
19
Median 3Y
25.9
Median 5Y
25.3
Industry
22.9
Forward
27.2
More Details
18.2
P/OCF
P/OCF
Price to OCF
18.2
vs History
76
vs Industry
24
Median 3Y
22
Median 5Y
26.1
Industry
17.1
More Details
40.1
P/FCFE
P/FCFE
Price to FCFE
40.1
vs History
26
vs Industry
14
Median 3Y
37.5
Median 5Y
-33.7
Industry
23.2
More Details
2.8
P/B
P/B
Price to Book Value
2.8
vs History
34
vs Industry
30
Median 3Y
2.8
Median 5Y
2.5
Industry
2.1
More Details
3
EV/S
EV/S
Enterprise Value to Sales
3
vs History
50
vs Industry
39
Median 3Y
3
Median 5Y
3
Industry
2.6
Forward
2.9
More Details
7.4
EV/GP
EV/GP
Enterprise Value to Gross Profit
7.4
vs History
36
vs Industry
30
Median 3Y
7.3
Median 5Y
7.1
Industry
5.1
More Details
25
EV/EBITDA
EV/EBITDA
Enterprise Value to EBITDA
25
vs History
47
vs Industry
15
Median 3Y
24.4
Median 5Y
25
Industry
13.6
Forward
17.9
More Details
25
EV/EBIT
EV/EBIT
Enterprise Value to EBIT
25
vs History
47
vs Industry
19
Median 3Y
24.4
Median 5Y
25
Industry
17
Forward
23.5
More Details
16.9
EV/OCF
EV/OCF
Enterprise Value to OCF
16.9
vs History
76
vs Industry
27
Median 3Y
19.9
Median 5Y
27.2
Industry
15.8
More Details
21.5
EV/FCFF
EV/FCFF
Enterprise Value to FCFF
21.5
vs History
57
vs Industry
20
Median 3Y
22.6
Median 5Y
27.3
Industry
17.6
More Details
2.9
EV/IC
EV/IC
Enterprise Value to IC
2.9
vs History
31
vs Industry
29
Median 3Y
2.9
Median 5Y
2.7
Industry
1.9
More Details

Multiples Across Competitors

Competitors Multiples
Changzhou Qianhong Biopharma Co Ltd Competitors

All Multiples
P/S
P/E
EV/EBITDA
EV/EBIT
All Countries
All Countries
Close
Market Cap P/S P/E EV/EBITDA EV/EBIT
CN
Changzhou Qianhong Biopharma Co Ltd
SZSE:002550
6.8B CNY 3.2 26.9 25 25
JP
Nichi-Iko Pharmaceutical Co Ltd
TSE:4541
776 550.9T JPY 4 211 733 -5 347 888.9 -5 459 134.4 -5 046 864.6
US
Eli Lilly and Co
NYSE:LLY
699.8B USD 20.4 133.3 60.3 69.3
DK
Novo Nordisk A/S
CSE:NOVO B
3.8T DKK 16.3 45.2 33 36
UK
Dechra Pharmaceuticals PLC
LSE:DPH
440.4B GBP 578.3 -15 783.5 3 846.3 17 702.3
US
Johnson & Johnson
NYSE:JNJ
356.7B USD 4.4 8.8 11.7 15.5
US
Merck & Co Inc
NYSE:MRK
322.3B USD 5.2 139.7 33.3 52.8
UK
AstraZeneca PLC
LSE:AZN
186.4B GBP 5.1 39.2 140.6 225.6
CH
Novartis AG
SIX:NOVN
180.1B CHF 4.2 13.3 9.7 16.1
CH
Roche Holding AG
SIX:ROG
172.6B CHF 2.9 15 8.6 10.2
US
Pfizer Inc
NYSE:PFE
155.8B USD 2.7 73.5 11 16.2

See Also

Summary
Intrinsic value, competitors valuation, and company profile.
DCF Valuation
Stock valuation using Discount Cash Flow valuation method.
Relative Valuation
Stock valuation using valuation multiples.
Wall Street Estimates
Price targets and financial estimates made by Wall st analysts.
Profitability Analysis
Detailed analysis of the company's profitability.
Solvency Analysis
Analysis of the financial position and solvency of the company.
Financials
Income Statement, Balance Sheet, Cash Flow Statement.
Discount Rate
Stock discount rate: cost of equity and WACC.
Summary
DCF Valuation
Relative Valuation
Wall Street Estimates
Profitability Analysis
Solvency Analysis
Financials
Discount Rate
Discover More
ALPHA SPREAD
Join more than 133,800+ value investors using Alpha Spread
Create a free account
or see our plans & pricing

Company

About Us Careers Pricing Affiliate Program Terms of Service Privacy Policy

Help

What is Intrinsic Value? Help Center Contact Us

Tools

Stock Screener Intrinsic Value Calculator DCF Value Calculator Discount Rate Calculator

Stocks

Most Undervalued Stocks High Profitability Stocks High Solvency Stocks Most Popular Stocks

© 2024 Alpha Spread Limited. All Rights Reserved.

www.alphaspread.com is not operated by a broker, a dealer, or a registered investment adviser. Under no circumstances does any information posted on www.alphaspread.com represent a recommendation to buy or sell a security. The information on this site, and in its related newsletters, is not intended to be, nor does it constitute, investment advice or recommendations. The information on this site is in no way guaranteed for completeness, accuracy or in any other way. In no event shall Alpha Spread Limited be liable to any member, guest or third party for any damages of any kind arising out of the use of any content or other material published or available on www.alphaspread.com, or relating to the use of, or inability to use, www.alphaspread.com or any content, including, without limitation, any investment losses, lost profits, lost opportunity, special, incidental, indirect, consequential or punitive damages. Past performance is a poor indicator of future performance.